These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 17887772)

  • 61. High-throughput methods for miniaturization and automation of monoclonal antibody purification processes.
    Treier K; Hansen S; Richter C; Diederich P; Hubbuch J; Lester P
    Biotechnol Prog; 2012; 28(3):723-32. PubMed ID: 22467605
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Large-scale purification of monoclonal antibodies for therapeutic use.
    Garg VK
    Targeted Diagn Ther; 1990; 3():45-73. PubMed ID: 2131018
    [No Abstract]   [Full Text] [Related]  

  • 63. Demonstration of robust host cell protein clearance in biopharmaceutical downstream processes.
    Shukla AA; Jiang C; Ma J; Rubacha M; Flansburg L; Lee SS
    Biotechnol Prog; 2008; 24(3):615-22. PubMed ID: 18410156
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Online integrity monitoring in the protein A step of mAb production processes-increasing reliability and process robustness.
    Bork C; Holdridge S; Walter M; Fallon E; Pohlscheidt M
    Biotechnol Prog; 2014; 30(2):383-90. PubMed ID: 24376144
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Protein purification using chromatography: selection of type, modelling and optimization of operating conditions.
    Asenjo JA; Andrews BA
    J Mol Recognit; 2009; 22(2):65-76. PubMed ID: 18546092
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Liquid chromatography of recombinant proteins and protein drugs.
    Geng X; Wang L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Apr; 866(1-2):133-53. PubMed ID: 18294930
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Non-size-based membrane chromatographic separation and analysis of monoclonal antibody aggregates.
    Wang L; Hale G; Ghosh R
    Anal Chem; 2006 Oct; 78(19):6863-7. PubMed ID: 17007507
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Combination of biotransformation and chromatography for the isolation and purification of mannoheptulose.
    Kappler-Tanudyaya N; Schmitt H; Tippkötter N; Meyer L; Lenzen S; Ulber R
    Biotechnol J; 2007 Jun; 2(6):692-9. PubMed ID: 17492712
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Innovative and economic potential of mammalian cell culture.
    Werner RG
    Arzneimittelforschung; 1998 Apr; 48(4):423-6. PubMed ID: 9608886
    [TBL] [Abstract][Full Text] [Related]  

  • 70. CHROM²--a method to enhance the dynamic binding capacity, yield and productivity of a chromatographic column.
    Puthirasigamany M; van Beijeren P; Kreis P
    J Chromatogr A; 2012 May; 1236():139-47. PubMed ID: 22436666
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Recovery and purification process development for monoclonal antibody production.
    Liu HF; Ma J; Winter C; Bayer R
    MAbs; 2010; 2(5):480-99. PubMed ID: 20647768
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Performance of a new protein A affinity membrane for the primary recovery of antibodies.
    Boi C; Dimartino S; Sarti GC
    Biotechnol Prog; 2008; 24(3):640-7. PubMed ID: 18473438
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Host cell protein clearance during protein A chromatography: development of an improved column wash step.
    Shukla AA; Hinckley P
    Biotechnol Prog; 2008; 24(5):1115-21. PubMed ID: 19194921
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Using partition designs to enhance purification process understanding.
    Pieracci J; Perry L; Conley L
    Biotechnol Bioeng; 2010 Dec; 107(5):814-24. PubMed ID: 20632374
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bioseparations.
    Lightfoot EN; Moscariello JS
    Biotechnol Bioeng; 2004 Aug; 87(3):259-73. PubMed ID: 15281101
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Recombinant antibody mixtures: production strategies and cost considerations.
    Rasmussen SK; Næsted H; Müller C; Tolstrup AB; Frandsen TP
    Arch Biochem Biophys; 2012 Oct; 526(2):139-45. PubMed ID: 22820097
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Optimal synthesis of protein purification processes.
    Vásquez-Alvarez E; Lienqueo ME; Pinto JM
    Biotechnol Prog; 2001; 17(4):685-96. PubMed ID: 11485430
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Application of a PEG/salt aqueous two-phase partition system for the recovery of monoclonal antibodies from unclarified transgenic tobacco extract.
    Platis D; Labrou NE
    Biotechnol J; 2009 Sep; 4(9):1320-7. PubMed ID: 19557796
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ultra scale-down approach to correct dispersive and retentive effects in small-scale columns when predicting larger scale elution profiles.
    Hutchinson N; Chhatre S; Baldascini H; Davies JL; Bracewell DG; Hoare M
    Biotechnol Prog; 2009; 25(4):1103-10. PubMed ID: 19569195
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Use of process data to assess chromatographic performance in production-scale protein purification columns.
    Larson TM; Davis J; Lam H; Cacia J
    Biotechnol Prog; 2003; 19(2):485-92. PubMed ID: 12675591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.